On Friday, December 11, 2020, The National Institute on Aging’s Penn U19 Center on Alpha-Synuclein Strains in Alzheimer’s Disease and Related Dementias (NIA U19) Clinical Core hosted a patient appreciation event that was open to participants of the study and anyone interested in gaining more information.
An overview of the NIA U19 was given by John Q. Trojanowski, MD, PhD, principal investigator, as well as a description of the work of the Clinical Core by Daniel Weintraub, MD, Clinical Core leader, and other core members including Sarah Shaw, Gina Mamikonyan and Julia Gallagher. Other topics included biomarkers in the NIA U19 and Parkinson’s Disease, discussed by Alice Chen-Plotkin, MD, as well as the clinical-pathological correlation in the NIA U19 by David Irwin, MD.
Above all, the key message throughout the event was gratitude for the patient’s dedicated participation and the value of the research in furthering our knowledge of Parkinson’s disease.
For more information, please contact:
Sarah Shaw at Sarah.Shaw@pennmedicine.upenn.edu